Resveratrol (3,5,4′-trihydroxystilbene) protects pregnant mother and fetus from the immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin

Attenuation of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicity by Resveratrol: A Comparative Study with Different Routes of Administration

(2009) Takumi Ishida et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters postnatal T cell phenotypes and T cell function and exacerbates autoimmune lupus in 24-week-old SNF1mice

(2009) Amjad Mustafa et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Resveratrol (Trans-3,5,4'-trihydroxystilbene) Induces Silent Mating Type Information Regulation-1 and Down-Regulates Nuclear Transcription Factor- B Activation to Abrogate Dextran Sulfate Sodium-Induced Colitis

(2009) U. P. Singh et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin

(2008) Ja Young Jang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The managed immune system: protecting the womb to delay the tomb

(2008) Rodney R Dietert et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Primary Peripheral T Cells Become Susceptible to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin-Mediated Apoptosis in Vitro upon Activation and in the Presence of Dendritic Cells

(2008) N. P. Singh et al.   MOLECULAR PHARMACOLOGY